Simon Fraser, DO
Vascular Surgery · Columbus, OHNPI 1659764280
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.9%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Medtronic at 50.3% of the total. 2025 is the largest year on record at $10,987, more than ten times the $338 reported in 2019.
Across 210 payments — averaging $120.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Shockwave Medical, Inc$4K
- W. L. Gore & Associates, Inc.$2K
- Silk Road Medical, Inc.$2K
- Cook Medical LLC$2K
- Endologix LLC$892
- plus $2K from 18 others
What the payments were for
- Consulting fees$3,30013%
- Grants$5,14820%
- Travel & lodging$3,72315%
- Food & beverage$12,62750%
- Education$5302%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 106 | $12,736 |
| Shockwave Medical, Inc | 18 | $4,302 |
| W. L. Gore & Associates, Inc. | 30 | $2,304 |
| Silk Road Medical, Inc. | 12 | $1,707 |
| Cook Medical LLC | 9 | $1,678 |
| Endologix LLC | 8 | $892 |
| Abbott | 3 | $273 |
| Inari Medical, Inc. | 2 | $262 |
| Kerecis Limited | 3 | $251 |
| Bolton Medical Inc | 2 | $181 |
| Innovation Technologies Inc | 1 | $145 |
| Penumbra, Inc. | 1 | $136 |
| Davol Inc. | 1 | $111 |
| Medical Device Business Services, Inc. | 1 | $89 |
| Prytime Medical Devices, Inc. | 1 | $43 |
| Lemaitre Vascular, Inc. | 3 | $38 |
| Boston Scientific | 2 | $37 |
| Philips North America LLC | 1 | $37 |
| Thrombolex, Inc. | 1 | $27 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| Cagent Vascular Inc | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$5,582
- Endurant$4,403
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,939
- ENROUTE Transcarotid Stent$1,485
- ENROUTE Transcarotid Neuroprotection System$1,485
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$542
- Kerecis Omega3 Marigen$537
- Alto Abdominal Stent Graft System$385
- GORE EXCLUDER AAA Endoprosthesis$347
- GORE TAG Conformable Thoracic Endoprosthesis$248
- FLOWTRIEVER CATHETER, S$221
- CT THROMBECTOMY SYSTEM KIT$221
- GORE TAG Thoracic Branch Endoprosthesis$195
- Torus Stent Graft System$181
- ENDOCROSS Device$181
- Kerecis Omega3 SurgiClose$179
- Kerecis Omega3 GraftGuide$179
- GORE EXCLUDER Iliac Branch Endoprosthesis$164
- Zenith$157
- Irrisept$145
How this compares
$25,327 in reported general payments places this provider in the 85th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 19 | $12,384 |
| ClopidogrelClopidogrel Bisulfate | 142 | $837 |
| Cilostazol | 43 | $411 |
| Atorvastatin Calcium | 49 | $298 |
| Gabapentin | 23 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $17 | $12,38419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 213 vascular surgery providers in Ohio.
Other vascular surgery in Columbus
- Kapil GopalColumbus$23K
- Charles PugarColumbus$19K
- Andrew YangColumbus$13K
- David EpsteinColumbus$11K
- Patrick MuckCincinnati$650K
- Sean LydenCleveland$561K
- Brian KuhnCincinnati$184K
- Vikram RaoWilloughby$137K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.